Skip to main content

Apyx Medical Corporation (APYX)

NASDAQ: APYX · Delayed Price · USD
11.48 0.42 (3.80%)
Sep 17, 2021 4:00 PM EDT - Market closed
Market Cap394.02M
Revenue (ttm)38.28M
Net Income (ttm)-14.20M
Shares Out34.32M
EPS (ttm)-0.41
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume156,693
Open11.01
Previous Close11.06
Day's Range10.55 - 11.51
52-Week Range4.35 - 12.01
Beta0.91
AnalystsBuy
Price Target14.00 (+22.0%)
Est. Earnings DateNov 8, 2021

About APYX

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and OEM. It offers electrosurgical generators based on its Helium Plasma Technology for cutting, coagulation, and ablation of soft tissue. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to ac...

IndustryHealth Care Equipment & Supplies
IPO DateJan 1, 1987
CEORobert Gershon
Employees266
Stock ExchangeNASDAQ
Ticker SymbolAPYX
Full Company Profile

Financial Performance

In 2020, Apyx Medical's revenue was $27.71 million, a decrease of -1.86% compared to the previous year's $28.24 million. Losses were -$11.90 million, -39.63% less than in 2019.

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for Apyx Medical stock is "Buy." The 12-month stock price forecast is 14.00, which is an increase of 21.95% from the latest price.

Price Target
$14.00
(21.95% upside)
Analyst Consensus: Buy

News

Apyx Medical Corporation to Participate in the Colliers Securities 2021 Institutional Investor Conference

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

2 weeks ago - Business Wire

Apyx Medical Corporation Announces Appointment of Wendy Levine to the Company's Board of Directors

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

3 weeks ago - Business Wire

Apyx Medical (APYX) Reports Q2 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of 14.29% and 25.27%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Apyx Medical Corporation Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Outlook

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

1 month ago - Business Wire

Will Apyx Medical (APYX) Report Negative Earnings Next Week? What You Should Know

Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

2 months ago - Business Wire

Apyx Medical Corporation to Participate in the JMP Securities Life Sciences Conference

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

3 months ago - Business Wire

Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of Renuvion® in Dermal Resurfacing Procedures

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

3 months ago - Business Wire

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of 0.00% and 9.80%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Apyx Medical Corporation Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Outlook

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

4 months ago - Business Wire

Analysts Estimate Apyx Medical (APYX) to Report a Decline in Earnings: What to Look Out for

Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2021 Financial Results on May 12, 2021

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

5 months ago - Business Wire

Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of 69.23% and 3.28%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Apyx Medical: Q4 Earnings Insights

Shares of Apyx Medical (NASDAQ:APYX) decreased 2.1% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 75.00% year over year to ($0.04), which beat th...

5 months ago - Benzinga

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2020 Financial Results; Introduces Full Year 2021 Finan...

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

5 months ago - Business Wire

Apyx Medical's Earnings: A Preview

Apyx Medical (NASDAQ:APYX) announces its next round of earnings this Wednesday, March 31. Here is Benzinga's everything-that-matters guide for this Wednesday's Q4 earnings announcement.

5 months ago - Benzinga

Will Apyx Medical (APYX) Report Negative Earnings Next Week? What You Should Know

Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

Apyx (APYX) Upgraded to Buy: What Does It Mean for the Stock?

Apyx (APYX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

6 months ago - Zacks Investment Research

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 31, 2021

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

7 months ago - Business Wire

Apyx Medical's (APYX) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Apyx Medical (APYX).

7 months ago - Zacks Investment Research

Here's Why Momentum Investors Will Love Apyx Medical (APYX)

Does Apyx Medical (APYX) have what it takes to be a top stock pick for momentum investors? Let's find out.

7 months ago - Zacks Investment Research

Apyx (APYX) Upgraded to Buy: Here's Why

Apyx (APYX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

8 months ago - Zacks Investment Research

Apyx Medical Corporation Reports Preliminary Full Year and Fourth Quarter 2020 Revenue Results

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

8 months ago - Business Wire

Apyx Medical Corporation to Participate in the ICR Conference 2021

CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...

8 months ago - Business Wire

Apyx (APYX) Upgraded to Buy: Here's What You Should Know

Apyx (APYX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

9 months ago - Zacks Investment Research